Loading
Life sciences · Journal article
Drug Development and Industrial Pharmacy · September 28, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
OBJECTIVE: Cervical cancer remains a major cause of illness and death among women worldwide, especially in low- and middle-income countries, where access to vaccination, screening, and advanced treatment is limited. SIGNIFICANCE: This review offers a comprehensive overview of the current evidence on cervical cancer, covering its epidemiology, molecular progression, clinical manifestations, diagnostic strategies, and emerging therapeutic approaches. It also emphasizes the integration of emerging technologies, particularly artificial intelligence, into cervical cancer screening, diagnosis, prognostic assessment, and treatment planning. In addition, it highlights recent advances in precision medicine, liquid biopsy, targeted therapies, immunotherapy, and nanotechnology-based drug delivery systems, while identifying current challenges and future research priorities. KEY FINDINGS: This review article pointed out the recent applied technologies for early diagnosis of cervical cancer e.g., biosensors which can overcome the limitations of immunohistochemistry and biochemical based assays. Therapeutic vaccines have also been developed as an alternative to therapeutic drugs and surgical operations for the prevention of cervical cancer. In addition, targeted delivery and nanotechnology applications in tumor diagnosis, investigation, and management as well as the delivery of HPV vaccines. Artificial intelligence (AI) has demonstrated considerable potential for the early detection of HPV infections and management of cervical cancer through surgical planning via AI-enhanced robotic systems. CONCLUSIONS: Cervical cancer research should focus on precision medicine, integrating recent models of artificial intelligence, advanced screening technologies, immunotherapy, and global public health initiatives. Combining these approaches could lead to improving early tumor detection, optimizing treatment outcomes, reducing disease burden, and contributing to eliminating cervical cancer.